Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Pen Needles Market To Reach USD 1.18 Billion By 2026 | Reports And Data

This image opens in the lightbox

News provided by

Reports And Data

24 Oct, 2019, 12:00 GMT

Share this article

Share toX

Share this article

Share toX

Pen Needles Market Size – USD 487.6 million in 2018, Market Growth - CAGR of 11.5%, Pen Needles Industry Trends – improvement in needle designs

A growing geriatric population, rising incidence of obesity and diabetes, favourable reimbursement plans, rising demand of minimal invasive therapy and market penetration into developing countries are key factors contributing to high CAGR of Pen Needles during the forecast period

NEW YORK, Oct. 24, 2019 /PRNewswire/ -- According to the current analysis of Reports and Data, the global pen needles market was valued at USD 487.6 million in 2018 and is expected to reach USD 1.18 billion by year 2026, at a CAGR of 11.5%. Pen needles are used by both healthcare providers and patients for administration of various injectable medications. Insulin administration for diabetic patients is a major application segment for pen needles. The advancement in the technology has resulted in increasing adoption of pen needles over conventional syringes. Their benefit lies in the ease of use and minimum pain while administrating medication, unlike the case with old-designed syringes.

Design is a major factor for product efficacy which is continuously worked upon for ensuring proper lubrication, minimum friction, and attached safety caps. Increasing incidences of chronic diseases such as, diabetes and cancer is one of the major factor contributing towards the growth worldwide. According to American Diabetes Association more than 30 million of the American population is diagnosed with diabetes and more than 84 million people have high risk of diabetes. Pen needle is majorly applicable in diabetes for the administration of insulin. Rising demand for minimal invasive treatment as the abortion of the therapy in middle of the treatment due to high anxiety level due to the pain associated with the administration of the drug is one of the key factor promoting the growth. Also, it does not require any professional skills.

Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/2124

Various market players are engaged in launching up the user friendly technology in the market. For instance, Novo Nordisk, one of the kay leader in diabetes market launched its NovoFine that features superflow technology to regulate higher flow without pain through its hairline thin gauze. North America holds the largest share in the global market by region. The well-established healthcare system and supportive reimbursement structure is supporting market growth. The developing countries are expected to observe lucrative growth because of an increasing incidence of disease and the increasing spending on healthcare. Despite a lucrative growth scenario, the preference for alternative modes of drug administration, and reuse of pen needles remain major challenges to be tackled for advancements in the pen needles market.

Further key findings from the report suggest

  • Based on type, the standard pen needles segment held the largest share. The growth is slowing down relatively because of associated risks such as lack of a safety shield, that can result in serious infections when not used carefully.
  • Based on therapy, the insulin segment is expected to register the fastest growth rate during the forecast period. The burgeoning geriatric population along with the high number of reported cases of diabetes is pushing the demand for this therapy.
  • The growth hormone therapy is expanding at a steady rate as it is being used more than before in order to stimulate growth and facilitate cell reproduction. Advancement in medical science is helping in a gradual accessibility to this therapy.
  • The 4 mm segment is growing at a fast rate of growth because of ease of insulin administration and the wide scale availability of this length of pen needles in the market.
  • By region, North America holds the largest share as of 2018 because of an increasing incidence of diabetes in the region. Government initiative to spread awareness about the product along with a favorable funding from many private players is leading the market growth.
  • The global market is highly competitive in nature. The top market players are constantly working on new technologies and products to enhance their global footprint. In January 2019, Becton, Dickinson and Co. launched an ergonomic pen needle technology, which has been designed for an enhanced injection depth.
  • Companies adopt both organic and inorganic growth strategies in order to ensure a steady pattern of growth. Acquisitions and mergers are commonly witnessed. In December 2017, BD acquired Bard to make use of the latter's product portfolio and innovation pipeline.

To identify the key trends in the industry, click on the link below:   https://www.reportsanddata.com/report-detail/pen-needles-market

Segments covered in the report:

For the purpose of this study, Reports and Data have segmented the Pen Needles market on the basis of type, length, therapy, mode of purchase, and region:                     

Type (Revenue, USD Million; 2016–2026)

  • Standard Pen Needles
  • Safety Pen Needles

Length (Revenue, USD Million; 2016–2026)     

  • 4 mm
  • 5 mm
  • 6 mm
  • 8 mm
  • 10 mm
  • 12 mm

Therapy (Revenue, USD Million; 2016–2026)

  • Insulin Therapy
  • Glucagon-Like Peptide-1 (GLP-1) Therapy
  • Growth Hormone Therapy
  • Others

Mode of Purchase (Revenue, USD Million; 2016–2026)     

  • Retail
  • Non-Retail

Order Now: https://www.reportsanddata.com/checkout-form/2124

By Region (Revenue, USD Million; 2016–2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America
    • Brazil

Browse more similar reports on Medical Devices category by Reports And Data

Dental X-Ray Market - https://www.reportsanddata.com/report-detail/dental-x-ray-market

Artificial Ventilators and Anesthesia Masks Market - https://www.reportsanddata.com/report-detail/artificial-ventilators-and-anesthesia-masks-market

Apheresis Equipment Market - https://www.reportsanddata.com/report-detail/apheresis-equipment-market

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John Watson
Head of Business Development
Reports And Data
Web: www.reportsanddata.com 
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

Logo: https://mma.prnewswire.com/media/1009077/Reports_And_Data_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.